Robert Yoder
Corporate Officer/Principal at TREVENA, INC.
Net worth: 73 083 $ as of 2024-03-30
Profile
Robert T.
Yoder is currently the Chief Business Officer & Senior Vice President at Trevena, Inc. Prior to his current position, he worked as the Head of Information Technology at Orexigen Therapeutics, Inc. from 2015 to 2018.
Mr. Yoder holds an MBA from Emory University and an undergraduate degree from Dickinson College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TREVENA, INC.
0.87% | 2023-12-13 | 158,877 ( 0.87% ) | 73 083 $ | 2024-03-30 |
Robert Yoder active positions
| Companies | Position | Start |
|---|---|---|
| TREVENA, INC. | Corporate Officer/Principal | 2018-12-09 |
Former positions of Robert Yoder
| Companies | Position | End |
|---|---|---|
| OREXIGEN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2018-05-31 |
Training of Robert Yoder
| Emory University | Masters Business Admin |
| Dickinson College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TREVENA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
- Stock Market
- Insiders
- Robert Yoder
